111 related articles for article (PubMed ID: 16456550)
41. The effect of endostatin evaluated in an experimental animal model of collagen-induced arthritis.
Kurosaka D; Yoshida K; Yasuda J; Yasuda C; Noda K; Furuya K; Ukichi T; Kingetsu I; Joh K; Yamaguchi N; Saito S; Yamada A
Scand J Rheumatol; 2007; 36(6):434-41. PubMed ID: 18092264
[TBL] [Abstract][Full Text] [Related]
42. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
Rivière C; Danos O; Douar AM
Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
[TBL] [Abstract][Full Text] [Related]
43. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
44. Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma.
Dickson PV; Hamner JB; Burger RA; Garcia E; Ouma AA; Kim SU; Ng CY; Gray JT; Aboody KS; Danks MK; Davidoff AM
J Pediatr Surg; 2007 Jan; 42(1):48-53. PubMed ID: 17208540
[TBL] [Abstract][Full Text] [Related]
45. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
[TBL] [Abstract][Full Text] [Related]
46. [A new antitumor agent--endostatin].
Xie QL; Chen XY; Zhang Q; Dai Y
Yao Xue Xue Bao; 2001 Jul; 36(7):552-4. PubMed ID: 12585093
[No Abstract] [Full Text] [Related]
47. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
[TBL] [Abstract][Full Text] [Related]
48. [Effects of double targeting gene therapy by suicide gene combined with endostatin gene in treatment of bladder cancer: an experimental study].
Pan JG; Zhou X; Han RF
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2700-4. PubMed ID: 19080691
[TBL] [Abstract][Full Text] [Related]
49. Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors.
Shao G; Greathouse K; Huang Q; Wang CM; Sferra TJ
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):168-79. PubMed ID: 16877980
[TBL] [Abstract][Full Text] [Related]
50. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells].
Yang F; He YL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):978-80. PubMed ID: 16864091
[TBL] [Abstract][Full Text] [Related]
51. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
[TBL] [Abstract][Full Text] [Related]
52. Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma.
Kamstock D; Guth A; Elmslie R; Kurzman I; Liggitt D; Coro L; Fairman J; Dow S
Cancer Gene Ther; 2006 Mar; 13(3):306-17. PubMed ID: 16138118
[TBL] [Abstract][Full Text] [Related]
53. Optimizing drug delivery for enhancing therapeutic efficacy of recombinant human endostatin in cancer treatment.
Xu F; Ma Q; Sha H
Crit Rev Ther Drug Carrier Syst; 2007; 24(5):445-92. PubMed ID: 18197781
[TBL] [Abstract][Full Text] [Related]
54. [Construction and activity of recombinant adeno-associated virus expressing vasostatin].
Diao Y; Ma J; Li X; Sun X; Xu R
Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1949-54. PubMed ID: 19256344
[TBL] [Abstract][Full Text] [Related]
55. AAV-mediated gene therapy for retinal disorders: from mouse to man.
Buch PK; Bainbridge JW; Ali RR
Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
[TBL] [Abstract][Full Text] [Related]
56. Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin.
Tan H; Yang S; Liu C; Cao J; Mu G; Wang F
Biomed Pharmacother; 2012 Dec; 66(8):648-54. PubMed ID: 23122594
[TBL] [Abstract][Full Text] [Related]
57. Effect of recombinant human endostatin on endometriosis in mice.
Jiang HQ; Li YL; Zou J
Chin Med J (Engl); 2007 Jul; 120(14):1241-6. PubMed ID: 17697575
[TBL] [Abstract][Full Text] [Related]
58. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
[TBL] [Abstract][Full Text] [Related]
59. Suppression of bladder cancer growth in mice by adeno-associated virus vector-mediated endostatin expression.
Pan JG; Zhou X; Zeng GW; Han RF
Tumour Biol; 2011 Apr; 32(2):301-10. PubMed ID: 21052889
[TBL] [Abstract][Full Text] [Related]
60. [Combining bevacizumab with endostatin gets better antitumor efficacy in vivo in lung cancer animal model].
Niu N; Li B; Liu C; Hu Y; Li X; Li J; Shi H; Zhang H
Zhongguo Fei Ai Za Zhi; 2013 Feb; 16(2):61-6. PubMed ID: 23425896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]